Recondo, G <br/><br/>
Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease.  [electronic resource] 

 -  Cancer  Nov 1991 
 - 2109-19 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19911115)68:10<2109::aid-cncr2820681004>3.0.co;2-m  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Drug Evaluation<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Pilot Projects<br/>Survival Analysis